Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

6.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia.

Blood and lymphatic cancer : targets and therapy·2026
Same author

Impaired dynein function preserves spinal interneuron survival and positioning in an ALS-like mouse model.

PloS one·2026
Same author

Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives.

Journal of medicinal chemistry·2025
Same author

Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL.

Cell death & disease·2025
Same author

Design, synthesis and evaluation of pyrrolobenzodiazepine (PBD)-based PROTAC conjugates for the selective degradation of the NF-κB RelA/p65 subunit.

RSC medicinal chemistry·2025
Same author

A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug Resistance.

Cancers·2025

Related Experiment Video

Updated: Sep 17, 2025

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:28

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

7

Computational modelling of aggressive B-cell lymphoma.

Eleanor S Jayawant1, Aimilia Vareli1, Andrea Pepper1

  • 1Department of Clinical and Experimental Medicine, Brighton & Sussex Medical School, University of Brighton and University of Sussex, Brighton BN1 9PX, U.K.

Biochemical Society Transactions
|July 4, 2025
PubMed
Summary

Computational models are unraveling lymphoma heterogeneity by integrating patient data with signaling knowledge. This approach promises to personalize diffuse large B-cell lymphoma treatments and improve patient outcomes.

Keywords:
cancercomputational biologycomputational modelslymphomasignallingsystems biology

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.9K
Using Optical Tweezers for the Generation of Hybrid Spheroids
12:11

Using Optical Tweezers for the Generation of Hybrid Spheroids

Published on: May 30, 2025

520

Related Experiment Videos

Last Updated: Sep 17, 2025

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:28

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

7
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.9K
Using Optical Tweezers for the Generation of Hybrid Spheroids
12:11

Using Optical Tweezers for the Generation of Hybrid Spheroids

Published on: May 30, 2025

520

Area of Science:

  • Oncology
  • Computational Biology
  • Bioinformatics

Background:

  • Diffuse large B-cell lymphoma (DLBCL) exhibits significant heterogeneity, leading to varied treatment responses.
  • Current therapies are often non-specific, resulting in relapsed/refractory disease in about one-third of patients.
  • Understanding the interplay of mutational burden and tumor microenvironment is crucial for improving lymphoma treatment outcomes.

Purpose of the Study:

  • To review the application of data-driven modeling, statistical approaches, and machine learning in understanding lymphoma heterogeneity.
  • To highlight how mechanistic computational models can integrate patient-specific data with biological signaling knowledge.
  • To discuss the potential of computational models in personalizing lymphoma treatment strategies.

Main Methods:

  • Review of data-driven modeling, statistical analysis, and machine learning techniques.
  • Focus on mechanistic computational models applied to recurrently dysregulated signaling networks (NF-κB, apoptosis, cell cycle) in lymphoma.
  • Analysis of recent advances in computational modeling for prognosis prediction and therapy identification.

Main Results:

  • Computational models offer a framework to embed patient data within signaling pathway knowledge.
  • Models have shown success in predicting prognosis and identifying potential combination therapies for lymphoma.
  • Digital twins developed using computational models can recapitulate clinical trial outcomes.

Conclusions:

  • Computational models are key to deciphering lymphoma's complex heterogeneity.
  • These models facilitate the transition towards personalized medicine in lymphoma treatment.
  • By identifying optimal treatments for individual patients, computational approaches promise improved outcomes for all lymphoma patients.